Protalix Biotherapeutics Correlations

PLX Stock

USD 1.79 0.05 2.87%

The current 90-days correlation between Protalix Biotherapeutics and Coherus BioSciences is -0.04 (i.e., Good diversification). The correlation of Protalix Biotherapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Protalix Biotherapeutics Correlation With Market

Weak diversification

The correlation between Protalix Biotherapeutics and DJI is 0.3 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Protalix Biotherapeutics and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Protalix Stock

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Protalix Biotherapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Protalix Stock please use our How to Invest in Protalix Biotherapeutics guide.

Moving together with Protalix Stock

0.62	PG	Procter Gamble	Pair Corr
0.77	HPQ	HP Inc	Pair Corr
0.85	HD	Home Depot	Pair Corr
0.87	MSFT	Microsoft Sell-off Trend	Pair Corr

Moving against Protalix Stock

0.89	CSCO	Cisco Systems	Pair Corr
0.85	AMGN	Amgen Inc	Pair Corr
0.85	MRK	Merck Company	Pair Corr
0.8	FTV	Fortive Corp	Pair Corr
0.78	KO	Coca Cola	Pair Corr
0.72	CAT	Caterpillar	Pair Corr
0.72	XOM	Exxon Mobil Corp Aggressive Push	Pair Corr
0.69	GILD	Gilead Sciences	Pair Corr
0.69	TRV	The Travelers Companies	Pair Corr
0.69	MCD	McDonalds	Pair Corr
0.67	AXP	American Express	Pair Corr
0.66	BAC	Bank of America	Pair Corr
0.52	MMM	3M Company	Pair Corr
0.43	IBM	International Business	Pair Corr
0.38	JPM	JPMorgan Chase Earnings Call This Week	Pair Corr

Related Correlations Analysis

	SLS	CHRS	IVVD	TARA	GNFT	CDXS	OABI	NTHI	MDWD	SGMO
SLS		0.04	0.36	-0.19	0.62	-0.15	0.43	-0.11	0.35	-0.15	SLS
CHRS	0.04		-0.66	-0.58	-0.54	0.9	-0.35	0.63	0.13	0.86	CHRS
IVVD	0.36	-0.66		0.55	0.76	-0.67	0.63	-0.73	0.27	-0.71	IVVD
TARA	-0.19	-0.58	0.55		0.26	-0.43	0.28	-0.49	-0.07	-0.43	TARA
GNFT	0.62	-0.54	0.76	0.26		-0.65	0.83	-0.5	0.29	-0.62	GNFT
CDXS	-0.15	0.9	-0.67	-0.43	-0.65		-0.42	0.62	0.05	0.96	CDXS
OABI	0.43	-0.35	0.63	0.28	0.83	-0.42		-0.31	0.37	-0.38	OABI
NTHI	-0.11	0.63	-0.73	-0.49	-0.5	0.62	-0.31		-0.01	0.69	NTHI
MDWD	0.35	0.13	0.27	-0.07	0.29	0.05	0.37	-0.01		-0.02	MDWD
SGMO	-0.15	0.86	-0.71	-0.43	-0.62	0.96	-0.38	0.69	-0.02		SGMO
	SLS	CHRS	IVVD	TARA	GNFT	CDXS	OABI	NTHI	MDWD	SGMO

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

SGMO	+ 0.96	CDXS
CDXS	+ 0.9	CHRS
SGMO	+ 0.86	CHRS
OABI	+ 0.83	GNFT
GNFT	+ 0.76	IVVD
SGMO	+ 0.69	NTHI

High negative correlations

NTHI	- 0.73	IVVD
SGMO	- 0.71	IVVD
CDXS	- 0.67	IVVD
IVVD	- 0.66	CHRS
CDXS	- 0.65	GNFT
SGMO	- 0.62	GNFT

Risk-Adjusted Indicators

There is a big difference between Protalix Stock performing well and Protalix Biotherapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Protalix Biotherapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
SLS	4.69	1.76	0.39	2.10	3.34	(5.52)	13.90	(7.26)	20.17
CHRS	3.68	(0.12)	0.00	0.23	0.00	0.00	7.52	(7.35)	19.01
IVVD	6.17	1.42	0.20	2.33	5.49	(7.12)	20.85	(10.92)	46.37
TARA	3.94	0.34	0.08	0.26	4.60	(4.65)	12.73	(7.72)	39.96
GNFT	3.22	0.84	0.16	(1.18)	3.55	(3.88)	8.47	(7.71)	25.18
CDXS	3.41	(0.71)	0.00	(0.26)	0.00	0.00	5.66	(6.56)	25.89
OABI	3.00	0.31	0.07	(5.02)	3.12	(3.85)	7.97	(5.16)	17.05
NTHI	5.53	(0.19)	0.01	0.04	7.35	(6.08)	12.62	(11.89)	41.97
MDWD	1.60	0.05	0.01	0.17	1.89	(1.93)	4.69	(3.44)	11.61
SGMO	3.76	(0.70)	0.00	(0.21)	0.00	0.00	7.69	(7.14)	23.61

Protalix Biotherapeutics Corporate Executives

Elected by the shareholders, the Protalix Biotherapeutics' board of directors comprises two types of representatives: Protalix Biotherapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Protalix. The board's role is to monitor Protalix Biotherapeutics' management team and ensure that shareholders' interests are well served. Protalix Biotherapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Protalix Biotherapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.

Gilad Mamlok

Senior CFO

Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC